Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women
2 other identifiers
interventional
99
1 country
1
Brief Summary
The purpose of this study is to test the feasibility of a stigma reduction intervention in Human Immunodeficiency Virus(HIV)-positive women using a video of first-person narratives delivered via personal Ipod Touch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2011
CompletedFirst Posted
Study publicly available on registry
June 30, 2011
CompletedStudy Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedOctober 22, 2014
October 1, 2014
2.5 years
June 14, 2011
October 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of implementing a stigma reduction intervention among Human Immunodeficiency Virus (HIV)-infected women
We will test whether the use of an Ipod Touch video intervention is feasible in this study population by comparing baseline data with data collected at 30 days into the intervention and upon completion of the intervention at 90 days.
90 days
Secondary Outcomes (5)
Acceptability of the use of a portable device to deliver a video intervention among Human Immunodeficiency Virus(HIV)-infected women
90 days
Utility of the use of a portable media device to deliver stigma-reduction intervention among Human Immunodeficiency Virus(HIV)-infected women
90 days
Change from baseline in levels of internalized stigma
90 days
Change from baseline in levels of coping self-efficacy
30 days, 90 days
Change in safe disclosure behaviors from baseline
90 days
Study Arms (2)
Received video intervention
EXPERIMENTALThe group of women who received an Ipod Touch with the video loaded onto it and told to view it at least once a week for the first 4 weeks, and as often as desired in weeks 5-12.
Did not receive video
NO INTERVENTIONThis group does not receive the video intervention during the study period, and will complete surveys at baseline, 30 days and 90 days for comparison to the intervention group.
Interventions
This group will be asked to watch the video on their Ipod Touch in its entirety at least once per week during the first four weeks of the study, and as often as desired in weeks 5-12. The participants will be asked to record the times viewed and their feelings/comments in a viewing log, and will be given surveys at 30 and 90 days.
Eligibility Criteria
You may qualify if:
- speaks, understands, and reads English
- Scores over 40 on Internalized Human Immunodeficiency Virus (HIV) Stigma Scale
- HIV positive
- mentally competent to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- National Institute of Nursing Research (NINR)collaborator
Study Sites (1)
Duke University clinics
Henderson, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Barroso, PhD
Duke University School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2011
First Posted
June 30, 2011
Study Start
July 1, 2011
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
October 22, 2014
Record last verified: 2014-10